The drug Remdesivir may decrease according to the manufacturer, the risk of death in a severe course of the Corona disease Covid-19 significantly.
A new analysis would show a reduction in the relative mortality risk by 62 percent, as the U.S. pharmaceutical company Gilead, at the conclusion of the world Aids conference has announced.
Remdesivir is the only one in the EU approved drug for the specific treatment of Covid-19.
The world Aids conference, which went down in the night of Saturday to the end, had taken place this year due to the Coronavirus pandemic, for the first time on the Internet and the pandemic is also on the agenda.
The pharmaceutical company Gilead, the mortality rate was higher in the standard therapy on day 14 after the start of treatment of hard-to Covid-19 patients at 12.5 percent. Patients were treated additionally with Remdesivir, died only 7.6 percent.
Taking into account these Figures, and other patient-related factors of Gilead, then by 62 percent through the drug lowered the risk of death.
Expert warns against too much hope
An independent expert, but would advise caution in the Interpretation of the data. Although the investigation would point to a good efficacy of the composition, said Uwe Janssens, President of the German Interdisciplinary Association for Intensive and emergency medicine (DIVI), the German press Agency.
However, the two groups were compared in the analysis should be in accordance with the applicable Standards not really compare.
So 312 patients from a particular study who were treated with Remdesivir stand on one side. In the second group of 818 patients who had, independently of this special study as a so-called historical comparison group, a standard therapy.
It is unclear whether these two groups had similar basic requirements regarding age, health, comorbidities, ethnicity, and other risk factors, says Janssens.
In order to verify the results, was a randomized, a so-called prospective clinical study is necessary, in the completely random patients in one of the two groups. It also Gilead itself draws attention.
Remdesivir was only approved a week ago by the EU Commission, because it reduces the recovery time in the cut from 15 to 11 days. Adequate data to support a decreased risk of death were not available at this time but still.
The USA have secured the majority of the to September is the targeted production amount of the composition. Germany has secured, according to the Ministry of health, but early Remdesivir supplies.
At the conclusion of the world Aids conference, especially the Coronavirus pandemic stand on Friday on the agenda. The United States had a “very serious Problem”, said the US immunologist Anthony Fauci. In numerous States in the United States, the case numbers rose again sharply.
The German AIDS help, warned, meanwhile, that the fight against the Coronavirus pandemic, should not throw the fight against Aids back. “HIV is now actually controllable,” said Sven Warminsky of the Board of Directors of AIDS help.
“Where the infection numbers rise again, and people dying of Aids, it is because not enough is being done. Corona brings a number of new hurdles and tying up enormous resources. This applies to even it out: The fight against an epidemic may not be the hard-won gains at a different cost.”
At the start of the Aids conference, the programme of the United Nations had informed on HIV/Aids (UNAIDS), the world community had failed to meet its self-imposed targets in the fight against HIV and Aids.
In the past year is, therefore, 1.7 million people worldwide with the Virus. Actually, it should be through new programs, initiatives and investments are only 500,000 people in the year. The epidemic should be defeated in 2030.
In 1985, for the first time, conducted Aids conference, which is considered to be the world’s largest Meeting on the topic, had to take place this year in San Francisco and Oakland, California, but was due to the Coronavirus pandemic, the Internet moved.
2018 were the previous world Aids conference in Amsterdam, around 15,000 experts in more than 160 countries travelled to the venue.
Deutsche Presse-Agentur (dpa)
*The article “treatment by Corona follow: Remdesivir lowers according to the manufacturer, the Covid-risk of death” will be released by FitForFun. Contact with the executives here.